Shuting Huang, Mengmeng Shang, Lu Guo, Xiao Sun, Shan Xiao, Dandan Shi, Dong Meng, Yading Zhao, Xiaoxuan Wang, Rui Liu, Jie Li
Pyroptosis, a novel type of programmed cell death (PCD), which provides a feasible therapeutic option for the treatment of tumors. However, due to the hypermethylation of the promoter, the critical protein Gasdermin E (GSDME) is lacking in the majority of cancer cells, which cannot start the pyroptosis process and leads to dissatisfactory therapeutic effects. Additionally, the quick clearance, systemic side effects, and low concentration at the tumor site of conventional pyroptosis reagents restrict their use in clinical cancer therapy...
April 20, 2024: Journal of Nanobiotechnology